Reported positive initial data from the Heart-2 Phase 1b clinical trial of VERVE-102 demonstrating dose-dependent decreases ...

DelveInsight's "LEQVIO Market Size, Forecast, and Market Insight Report" highlights the details around LEQVIO, which is a ...

but other abnormalities due to lack of LDL receptors include altered hepatic cholesterol trafficking, increased apoB turnover, increased lipoprotein(a) and possibly decreased transintestinal ...

PCSK9 prevents LDL receptors from "recycling" to the surface of hepatocytes or liver cells where they remove LDL-C from circulation. PCSK9 inhibitors increase the density of the receptors on the ...

Activation of the GLP-1 and glucagon receptors is believed to mimic the complementary ... and robust reductions in ...

GAITHERSBURG, Md., May 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and ...

Q2 2025 Earnings Call Transcript May 12, 2025 Arrowhead Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $2 ...

Family history of heart disease means you need lower cholesterol numbers. Discover the specific targets that can save your ...

DelveInsight's analysis forecasts liver fibrosis market growth due to the introduction of emerging therapies, expecting an increase in market ...

The 100 dieters in Dr Norwitz’s study showed their liver was producing large ... The participants also had fully functioning LDL receptors and didn't need to be put on a statin.

When the liver makes less LDL cholesterol, the body produces more LDL receptors. LDL receptors are a type of protein on cells that move LDL cholesterol from your blood into your cells. This lowers ...